2018 is moving along and so is Startup Grind Baltimore. Our February event is the perfect opportunity to check out the newly formed University of Maryland, Baltimore's Graduate Research Innovation District (The Grid). The space is awesome and we have a fantastic speaker with Marco Chacon, a seasoned biopharmaceutical executive and entrepreneur, who is the Founder and Chairman of Paragon Bioservices, Inc.
We're going to be adding a new component to our event; a time for startups to practice their pitch in front of a crowd. It's a great opportunity to show off your business, hone your pitch skills and get valuable feedback from the community. If you are interested it pitching, please request to be a featured guest (for added exposure), and email me at firstname.lastname@example.org so I can put you on the list. We're only going to have time for a few startups pitch, so please get your request in ASAP.
This chapter and community only grows and thrives if you come out to support us and spread to the word to friends and collegues. Come on out, help build the community and be a part of something amazing in our great city.
Marco A. Chacon, Ph.D. is the Assistant Vice President of Industry Alliances the University of Maryland. He is the Founder and Chairman of Paragon Bioservices, Inc., specializing in the development and GMP manufacturing of viral vectors and vaccines. He is also the Founder of IRAZU Biodiscovery, a regenerative medicine company.Read More
Marco A. Chacon, Ph.D. is the Assistant Vice President of Industry Alliances the University of Maryland, Baltimore. As a seasoned biopharmaceutical executive and entrepreneur, Dr. Chacon works with the leadership team at UMB leading special projects to grow the BioPark tenant base and to strengthen the University’s research collaborations with industry.
Dr. Chacon is the Founder and Chairman of Paragon Bioservices, Inc., a Contract Development and GMP Manufacturing Organization (CDMO) located at the University of Maryland BioPark in Baltimore. With nearly 200 employees and 75,000 square feet of space, Paragon specializes in the development and GMP manufacturing of viral vectors and vaccines.
He is also the Founder of IRAZU Biodiscovery, a regenerative medicine company seeking to develop therapeutic interventions to induce hypoxia tolerance and neuroprotection as described in experimental models of caloric restriction and hibernation, as well as during the neonatal period in mammals.
His academic interests include control of metabolism, oxygen homeostasis and the regenerative potential of tissues and organs.
Dr. Chacon received a B.S. degree from Youngstown State University and a Ph.D. Degree from the University of Maryland, College Park. He currently serves on the Board of Trustees of the UMB Foundation and was appointed in 2016 to the Life Sciences Advisory Board by Maryland Governor Lawrence J. Hogan, Jr.